v3.26.1
Condensed Consolidated Statements of Cash Flow (Unaudited) - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
OPERATING ACTIVITIES    
Net Income (Loss) $ 164,552 $ (22,003)
Non-cash items:    
Depreciation 22 341
Loss on impairment of leasehold improvements and lab equipment 0 2,811
Stock-based compensation expense 2,984 4,428
Change in fair value of contingent consideration 422 559
Non-cash royalty revenue (361) (974)
Non-cash interest expense 30 55
Net accretion and amortization of investments in marketable securities (675) (1,386)
Net change in operating items:    
Accounts receivable 1,078 1,384
Increase (Decrease) in Accounts and Other Receivables (179,373) 0
Prepaid expenses and other assets 20 (640)
Accounts payable and accrued liabilities (2,609) (3,056)
Change in deferred license revenue 0 (10,434)
Other liabilities (218) (225)
Net cash used in operating activities (14,128) (29,140)
INVESTING ACTIVITIES    
Purchase of investments in marketable securities (37,462) (63,214)
Proceeds from sale of property and equipment 0 9
Disposition of investments in marketable securities 38,000 90,165
Net cash provided by investing activities 538 26,960
FINANCING ACTIVITIES    
Issuance of common shares pursuant to exercise of stock options 14,679 3,106
Issuance of common shares pursuant to ESPP 88 131
Net cash provided by financing activities 14,767 3,237
Effect of foreign exchange rate changes on cash and cash equivalents (14) 25
Increase in cash and cash equivalents 1,163 1,082
Cash and cash equivalents, beginning of period 18,008 36,330
Cash and cash equivalents, end of period $ 19,171 $ 37,412